Nitto Avecia
Perry McGriff is a research scientist with extensive experience in analytical chemistry and environmental laboratory services. Currently working at Nitto Avecia since February 2022, Perry previously held roles at Access Analytical Labs as a chemist and at SI Group as an analytical services laboratory chemist, where responsibilities included maintaining compliance with cGMP, ASTM, ISO, EPA, and DHEC guidelines, as well as expertise in pharmaceutical analyses, particularly in Ibuprofen stability testing. Earlier experience includes serving as a laboratory waste coordinator and inorganic non-metals analyst at Shealy Environmental Services, where Perry was responsible for laboratory waste disposal and regulatory compliance. Perry holds a Bachelor of Science degree in Chemistry from the University of South Carolina, completed in 2006.
This person is not in the org chart
Nitto Avecia
1 followers
Oligonucleotides are giving rise to a new generation of therapeutics—and Nitto Avecia is helping lead the way. With more than 25 years’ experience in oligonucleotide development and production, we are the partner of choice for pharmaceutical innovators creating new drugs with the power to transform treatment for a wide range of diseases. In partnership with Nitto Avecia Pharma Services, Nitto Avecia is the first CMO that offers a comprehensive, end-to-end oligonucleotide solution. This offers the advantage of a single, expert partner handling the entire process—from drug substance through drug product manufacturing—with flexible solutions and consistent reliability and quality.